Form 4: InspireMD Director Buys 5,073 Shares

InspireMD Director Paul Stuka acquired 5,073 shares of the company's common stock at a weighted average price of $1.81 per share.

Summary

• Paul Stuka, a Director of InspireMD, Inc. (NSPR), acquired 5,073 shares of common stock.
• The transaction occurred on December 9, 2025, at a weighted average price of $1.81 per share, with prices ranging from $1.80 to $1.81.
• Following this transaction, Paul Stuka directly beneficially owns 391,628 shares of common stock.
• An additional 444,195 shares are indirectly beneficially owned through Osiris Investment Partners, L.P., where Mr. Stuka serves as the managing member of the general partner, though he disclaims beneficial ownership except to the extent of his pecuniary interest.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director is generally viewed as a positive indicator of management's confidence in the company's future performance and valuation.

Positives

• A Director's acquisition of company shares signals confidence in the company's future prospects and valuation.
• The purchase price of $1.81 per share indicates management's belief in the stock's value at or above this level.

Negatives

• No negative information is typically disclosed in a Form 4 filing, which solely reports insider transactions.

Risks

• This filing does not contain information regarding company-specific risks.

Industry Context

Insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those with intimate knowledge of the company believe the stock is undervalued or has strong future potential. This type of transaction can sometimes precede positive company developments or improved financial performance.

Stakeholder Impact

• Shareholders: May view the director's purchase as a sign of confidence, potentially leading to increased investor interest.
• Employees: Could interpret the insider buying as a positive signal regarding the company's stability and future.

Key Dates

Recommendation

While a single insider purchase is a positive signal, it is not sufficient on its own to warrant a 'buy' recommendation. It suggests confidence from a key insider, which can be a good sign for existing shareholders to 'hold' their positions, but further fundamental analysis would be required for a stronger recommendation.

Keywords

InspireMD, NSPR, Paul Stuka, Director, Insider Trading, Share Acquisition, Common Stock, Form 4, Beneficial Ownership